- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01519180
Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis
September 5, 2014 updated by: University Hospital, Rouen
Study of the Antro-pyloro-duodenal Motor Dysfunction in Idiopathic Gastroparesis
Impaired gastric emptying may cause dyspeptic symptoms including nausea, vomiting and even nutritionnal impairment.
Delay in gastric emptying may result from antro-pyloro-duodenal motility impairement.
Study Overview
Status
Completed
Conditions
Detailed Description
The aim of this study is therefore to measure antro-pyloro-duodenal motor activity in patients with idiopathic gastroparesis.
Study Type
Observational
Enrollment (Actual)
32
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Haute normandie
-
Rouen, Haute normandie, France, 76000
- Service de Physiologie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Idiopathic gastroparesis and healthy volunteers
Description
Inclusion Criteria:
- Idiopathic gastroparesis or healthy volunteers
- Idiopathic gastroparesis must have delayed gastric emptying shown using C13 breath test
Exclusion Criteria:
- Diabetic or post-surgical gastroparesis
- Treatment modifying GI motility (prokinetics, opioids...)
- Parkinson or neurologic disease
- Evoluting inflammatory process or neoplasia
- Treatment modifying coagulation
- Patients not affiliated to the French healthcare insurance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Control group
Healthy volunteers
|
Idiopathic gastroparesis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
antro-pyloro-duodenal pressure
Time Frame: 3h
|
the main outcome is the pressure measured using pressure sensors within the antrum, the pylorus, and the first part of the duodenum.
This will be measured during 3h fast.
Pressures measured in the antrum, the pylorus, and the duodenum wiil be compared between healthy volunteers and gastroparetic patients
|
3h
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Guillaume Gourcerol, MD, PhD, CHU de ROUEN
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
January 18, 2012
First Submitted That Met QC Criteria
January 25, 2012
First Posted (Estimate)
January 26, 2012
Study Record Updates
Last Update Posted (Estimate)
September 8, 2014
Last Update Submitted That Met QC Criteria
September 5, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010/148/HP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroparesis
-
Johns Hopkins UniversityCompletedDiabetic Gastroparesis | Idiopathic Gastroparesis | Gastroparesis PostoperativeUnited States
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedGastroparesis | Diabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
Vanda PharmaceuticalsRecruitingGastroparesis | Diabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
Neurogastrx, Inc.CompletedDiabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
Texas Tech University Health Sciences Center, El...CompletedDiabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
TakedaCompletedDiabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University; Massachusetts General Hospital; National Institute... and other collaboratorsCompletedGastroparesis | Diabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
Millennium Pharmaceuticals, Inc.CompletedDiabetic Gastroparesis | Idiopathic GastroparesisUnited States, Belgium, Japan, Poland
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitationFunctional Dyspepsia | Diabetics Without Symptoms of Gastroparesis | Diabetic Gastroparesis | Idiopathic Gastroparesis | Total or Partial Gastrectomy | Chronic NauseaUnited States
-
University of Erlangen-Nürnberg Medical SchoolNot yet recruiting